Accipiter Biosciences
Accipiter Biosciences uses computational protein design to develop de novo protein therapies that engage multiple cell-surface receptors and pathways in one stable molecule. Its therapies are designed for complex diseases, including autoimmune disorders and cancer, as an alternative to combination treatments.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2023 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 26
- Registered name
- Accipiter Biosciences Inc Seattle business license
- Stage
- Seed
- Members see funding amounts. .
Is this your organization? Claim it
Accipiter Bio raises $10.5M more to speed AI-designed multi-target protein drugs, expanding clinical pipeline
Seattle biotech Accipiter Bio raised an additional $10.5 million from existing investors to accelerate development of AI-designed multi-target protein therapeutics and expand its team and clinical pipeline. The company, now 22 people strong and partnered with Pfizer and Kite/Gilead, will use the funds to advance three to four programs—focusing mainly on immunology alongside oncology—after emerging from stealth last year with $12.7 million.
Bill Gates-Backed Modern Hydrogen Lays Off Most Employees; TerraPower Gets NRC Nod for First Nuclear Plant
GeekWire's most popular stories for the week of Nov. 30, 2025 include Bill Gates-backed Modern Hydrogen laying off most staff due to funding changes, TerraPower receiving NRC approval for a nuclear plant, and new AI advancements in protein design from University of Washington. Other highlights include Amazon launching a 30-minute delivery service, discussions on a proposed Washington payroll tax affecting tech companies, and debates about Seattle's attitude toward AI.
GeekWire's Top Tech Stories for Week of Nov. 2, 2025: AI Antibodies, Startup Moves, and Amazon's New Whole Foods Model
GeekWire's most popular stories for the week of Nov. 2, 2025, featured breakthroughs like AI-designed antibodies from Nobel laureate David Baker's lab, entrepreneurial ventures blending tech and ballet, ethical discussions on layoffs at Microsoft and Amazon, and innovative retail concepts by Amazon at Whole Foods.
See all 4 stories, episodes and videos about Accipiter Biosciences.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Matthew Bick co-founder and Chief Executive Officer
-
Hector Rincon-Arano Co-founder and Chief Scientific Officer
-
Javier Castellanos Co-founder and Chief Technology Officer